Press "Enter" to skip to content

New patent for Amarin Pharms drug VASCEPA

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for VASCEPA
Annual Drug Patent Expirations for VASCEPA

Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are seventy patents protecting this drug and three Paragraph IV challenges.

VASCEPA drug price trends.

Drug patent litigation for VASCEPA.

This drug has three hundred and eleven patent family members in forty-five countries.

The generic ingredient in VASCEPA is icosapent ethyl. Two suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions